This is Dr. Volkova’s story.
How to sell a behavioral health business at the right time, to the right buyer, for the right price was the question Dr. Anna Volkova had been turning over in her mind for almost five months before she picked up the phone. When the right time came, Anna called CGK Business Sales. Anna, age 44, BCBA-D (Board Certified Behavior Analyst-Doctoral), Russian-American by birth and bilingual in English and Russian, ran a $7.2M revenue, $1.8M EBITDA six-clinic ABA therapy and IDD-focused outpatient platform across the DC metro, with the main clinic on Rockville Pike near the Twinbrook Metro corridor in Montgomery County, plus satellite clinics in Bethesda, Silver Spring, Gaithersburg, Columbia, and Frederick covering both Montgomery County and Howard County. Eighty-five W-2 employees ran the six sites: Anna herself as Clinical Director, six BCBAs (board-certified behavior analysts, the credentialed clinical layer) anchoring each site, four BCaBAs (assistant analysts), fifty-eight RBTs (Registered Behavior Technicians, the front-line direct-service staff), eight case managers, six administrative and billing personnel, and three quality and compliance team members. The platform was clinically deep on purpose, because behavioral health buyers underwrite clinical bench depth before they underwrite anything else when they evaluate ABA practices for autism services and IDD-focused operations. Anna’s revenue mix was 65 percent ABA therapy for children with autism spectrum disorder ages two through eighteen (the regulated and licensed core, delivered both at the clinic and in the home), 20 percent IDD adolescent and young-adult services (continuation of ABA through ages eighteen through twenty-six plus structured day-program services for IDD adults), 10 percent telehealth-delivered parent training and ABA supervision (not direct telehealth therapy, since research shows direct delivery is less effective, but supervision and parent coaching), and 5 percent in-school behavioral consultation services for the Montgomery County and Howard County school districts. The single most important operating fact about the practice (the fact that drove the eventual multiple) was the 100 percent in-network payor mix Anna had built deliberately over twelve years. Fifty percent of her revenue came from the Maryland Department of Health Developmental Disabilities Administration (the Maryland DDA waiver program, which functions as the largest Medicaid payor for ABA and IDD services in the state). Thirty percent came from the major commercial carriers (CareFirst BCBS, Aetna, UnitedHealthcare, Cigna, all credentialed in-network). Twelve percent came from Tricare, serving DC metro military families through the NIH and the broader Department of Defense biomedical-research community. Eight percent came from private-pay self-funded families. Approximately 480 active patients sat on the active treatment cohort across the six clinics receiving regular ABA therapy (typical fifteen to twenty-five hours per week of treatment per child), plus another 120 IDD young-adult clients across the day programs, plus 80 in-school consultation cases. Average patient tenure ran 3.4 years, long because autism therapy is a developmental commitment from age two through adolescence, and the active patient cohort grew roughly 8 percent per quarter through pediatrician referrals (the largest channel, because pediatricians refer to Anna’s network on clinical reputation), Montgomery County Public Schools special education department referrals, and the Russian-speaking immigrant community network across Montgomery County. The practice held BHCOE accreditation (Behavioral Health Center of Excellence, the ABA-industry equivalent of CARF or Joint Commission, carried by only about 15 percent of US ABA providers), a Maryland Board of Professional Counselors and Therapists license across all BCBAs (Maryland is stricter than most states on BCBA-level licensure), and a measured 89 percent twelve-month RBT retention rate against an industry average closer to 55 to 65 percent. Anna’s husband Pavel, a software engineer at NIH, was offered a senior leadership role at a Boston-based biotech AI company in early 2026. The family is relocating. Anna wants the practice to continue operating under strong clinical leadership and the right strategic acquirer rather than wind down. She came to us because she did not know who else to talk to about how to sell a behavioral health business at this size, with six clinics covering Montgomery and Howard counties, the 100 percent in-network payor base, BHCOE accreditation, the 89 percent RBT retention rate, the Maryland DDA waiver program contract, the Montgomery County Public Schools partnership, and the bilingual English-Russian intake team she had built specifically for the DC metro Russian-speaking immigrant community. This page is what happened next, and what could happen for you. Anna is a composite, not a single real CGK seller, but the patterns and details are pulled from real ABA, autism services, and IDD-focused engagements.
The night before Anna decided to sell a behavioral health business.
Most BCBAs who decide to sell a behavioral health business have been sitting with the question quietly for months before they reach for the phone. Anna was no different. She was 44. For twelve years she had been the founding Clinical Director of a six-clinic ABA therapy and IDD-focused outpatient platform across the DC metro, the BCBA who had personally signed the original lease in 2014 on the Rockville Pike main clinic in Montgomery County after she left a regional autism services platform, the credentialing lead on the Maryland DDA waiver program contract, and the relationship lead on every commercial in-network agreement across the platform. The practice did $7.2 million in annual revenue, $1.8 million in EBITDA at the upper end of large-band ABA and IDD-focused norms (driven by the 100 percent in-network payor mix, the six-clinic geographic moat across Montgomery County and Howard County, the BHCOE accreditation, the 89 percent twelve-month RBT retention rate, the Maryland DDA waiver program contract, and the Montgomery County Public Schools partnership), and an 85-person W-2 team across the six sites. Anna led the platform clinically as Clinical Director. Six BCBAs anchored each clinic site as the credentialed clinical layer. Four BCaBAs supported the BCBA bench. Fifty-eight RBTs delivered the front-line one-on-one direct service across the clinic and the home settings. Eight case managers coordinated school-district, pediatrician-referral, and Maryland DDA waiver program eligibility workflows. Six administrative and billing personnel ran the front office across the six clinics. A three-person quality and compliance team owned the BHCOE survey readiness, the Maryland Board of Professional Counselors and Therapists license renewal cadence, the Maryland DDA provider contract compliance, and the payor credentialing rhythm across CareFirst BCBS, Aetna, UnitedHealthcare, Cigna, and Tricare. Approximately 480 active ABA patients sat on the regular-treatment cohort at any given time, plus 120 IDD young-adult clients across the day programs, plus 80 in-school consultation cases. The active ABA cohort grew roughly 8 percent per quarter through pediatrician referrals (the largest acquisition channel because pediatricians refer to Anna’s network on clinical reputation in the DC metro autism services community), Montgomery County Public Schools special education department referrals, and the Russian-speaking immigrant community network across Rockville and Bethesda. Twelve-month RBT retention ran at 89 percent, against an industry average closer to 55 to 65 percent. RBT turnover is the single biggest operational pain in the ABA industry, and Anna’s retention number was exceptional, the operational story a sophisticated buyer would underwrite first.
Why BCBAs decide to sell a behavioral health business
The Tuesday Anna finally submitted the form, she had been at the Rockville Pike main clinic for the morning intake huddle when Pavel called from NIH with an update. The Boston-based biotech AI company had finalized the offer letter for Pavel’s senior leadership role and the relocation timeline was firm: family on the ground in Boston by August. Anna’s husband had been gentle but consistent across the prior five months: she had built something, the ABA M&A market in 2025 and 2026 was extraordinarily active for in-network operators with BHCOE accreditation and meaningful Medicaid waiver footprints, the Boston move was waiting, their children Sasha (13) and Mira (10) were already accepting the move, Anna’s parents (in Rockville since 1991) were following them to Boston for proximity to the grandchildren, and the next chapter was on a real timeline. Her six BCBAs, the credentialed clinical layer across each site, were committed to staying on post-close if the buyer kept the clinical-leadership structure intact and ran the six sites under their existing BHCOE accreditation umbrella. Anna had been approached eleven times in the prior eighteen months: seven times by PE-backed ABA and behavioral health consolidators headquartered out of Detroit, Boston, Dallas, and a handful of national platforms, three times by regional Mid-Atlantic ABA operators expanding their DC, Maryland, and Virginia footprint, and once by a single Maryland health system trying to vertically integrate an autism services platform into its developmental pediatrics service line. Anna did not know what her platform was actually worth at $7.2 million revenue and $1.8 million EBITDA, with six clinics covering Montgomery County and Howard County, 480 active ABA patients plus 120 IDD young-adult clients plus 80 in-school consultation cases, a 100 percent in-network payor base, BHCOE accreditation, an 89 percent RBT retention rate, a Maryland DDA waiver program contract, a Montgomery County Public Schools partnership, and the bilingual English-Russian intake team. She did not know whether the firms calling her were the right buyers for her six BCBAs, her four BCaBAs, her fifty-eight RBTs, or the brand she had built across the DC metro autism services community. She did not know whether the 100 percent in-network status was a value driver or a structural premium-multiple anchor for a sophisticated PE-backed ABA consolidator. She did not have a single peer in her life who had ever sold an ABA platform at this size, payor mix, and multi-site footprint.
That is the Tuesday she found CGK and submitted the form. We called her back at 8:11 the next morning, while Anna was at the Rockville Pike main clinic finishing the morning supervision sign-off with two of the BCBAs before the 9:00 a.m. team huddle.
The first call about how to sell a behavioral health business.
The first call was 47 minutes. We did most of the listening.
BCBAs who think about how to sell a behavioral health business in their mid-forties, like Anna, usually carry the same handful of pressures into the first call. Anna talked about her six BCBAs (the credentialed clinical layer anchoring each site), about the way each had become the clinical anchor for the long-tenure ABA caseload at one of the six clinics. She talked about the four BCaBAs who supported the BCBA bench across supervision-hour load. She talked about the fifty-eight RBTs who delivered the front-line direct-service work, the layer where ABA practices live or die operationally. She talked about the 89 percent twelve-month RBT retention rate she had built deliberately through above-market RBT comp, structured supervision pathways toward BCaBA and BCBA credentialing, and a culture deliberately designed to keep RBTs engaged in a profession with industry-average churn closer to 55 to 65 percent. She talked about the eight case managers who coordinated the pediatrician-referral, Montgomery County Public Schools, and Maryland DDA waiver program workflows. She talked about the six-person front-office administrative and billing team. She talked about the three-person quality and compliance team that owned the BHCOE survey, the Maryland Board of Professional Counselors and Therapists license renewals across all BCBAs, the Maryland DDA provider contract compliance, and the payor credentialing rhythm. She talked about the 480 active ABA patients across the six clinics, the average 3.4-year tenure, the 8 percent quarterly cohort growth, and the way pediatrician referrals carried the largest share of new patient acquisition. She talked about the 120 IDD young-adult clients across the day programs and the 80 in-school consultation cases. She talked about the 100 percent in-network payor mix and the way she had deliberately built credentialing across CareFirst BCBS, Aetna, UnitedHealthcare, Cigna, and Tricare over twelve years rather than running an out-of-network billing model. She talked about the Maryland DDA waiver program contract that delivered roughly half the practice revenue. She talked about the BHCOE accreditation that placed her in the top 15 percent of US ABA providers. She talked about the CentralReach ABA practice management platform she had standardized across the six clinics. She talked about the Montgomery County Public Schools partnership for in-school behavioral consultation that gave the practice institutional credibility. She talked about the bilingual English-Russian intake team built specifically to serve the DC metro Russian-speaking immigrant community. She talked about Pavel, the Boston offer, Sasha and Mira accepting the move, and her parents following them to Boston. We asked about the platform the way you would ask if you were trying to understand it, not the way you would ask if you were trying to win the engagement. What we were listening for was not just the financials. We were listening for whether Anna was actually ready to sell, what she was working toward, and whether her expectations on price were grounded in what the ABA M&A market would actually support for an in-network, BHCOE-accredited, multi-clinic ABA and IDD-focused platform of her size.
At the end of that call, we set up a working session: an in-person conversation where one of our Managing Directors would walk Anna through our valuation model and tell her honestly what her platform was likely to command. We did not promise her a written report. Written valuations involve substantially more work, and we charge for those when a seller actually needs one for partnership buyout, estate planning, a divorce, or another documentary purpose. The walkthrough was free because Anna was clearly thinking seriously about how to sell a behavioral health business, the way someone thinks about it before they actually do it. Whether that ends up being in a year, five years, or longer, we make the same call.
The valuation session was the following Friday at 7:30 a.m. at the Rockville Pike main clinic, before the 8:30 a.m. clinical case conference and after Anna had finished the BCBA supervision sign-off rotation with the director of clinical services.
Anna was not ready to sell a behavioral health business yet. She went home and waited three months.
The valuation session showed Anna that her platform was worth meaningfully more than she had been hoping in some areas and meaningfully less in others, which is how these conversations usually go. The 100 percent in-network payor mix (the single most important value driver for any ABA platform in 2026, because PE-backed ABA consolidators structurally refuse to acquire out-of-network operators), the six-clinic geographic moat across Montgomery County and Howard County, the BHCOE accreditation that placed her in the top 15 percent of US ABA providers, the 89 percent twelve-month RBT retention rate against an industry average closer to 55 to 65 percent, the Maryland DDA waiver program contract that anchored roughly half the practice revenue under a recurring multi-year Medicaid framework, the pediatrician referral pipeline that carried the largest share of new patient acquisition, the Montgomery County Public Schools partnership that delivered institutional credibility plus a 5 percent in-school consultation revenue line, the CentralReach ABA practice management platform standardization across the six clinics, the Maryland Board of Professional Counselors and Therapists licensure documented across all six BCBAs, the twelve-year operating history under a single founding BCBA-D, and the bilingual English-Russian intake capacity were all premium-multiple drivers a sophisticated PE-backed ABA consolidator would pay up for. Three issues, though, were dragging the number down. The first was the per-clinic BHCOE survey-readiness binder variance. The Rockville Pike main clinic carried a tight, audit-ready binder owned by the three-person quality and compliance team. The five satellites (Bethesda, Silver Spring, Gaithersburg, Columbia, Frederick) carried thinner binders that had not been refreshed in the prior twelve months. A buyer’s diligence team was going to pressure-test per-clinic BHCOE survey readiness as part of LOI formulation, because BHCOE survey continuity is a buyer-side regulatory-risk factor that translates directly into multiple. The second was the Maryland DDA waiver program contract documentation. Anna knew the Maryland DDA waiver program anchored roughly half the practice revenue, but she had not built a formal Maryland DDA contract continuity binder that documented the next renewal cycle, the per-clinic provider enrollment status, the rate-setting history across the trailing thirty-six months, and the per-service-type DDA billing accuracy and claim-denial patterns. A sophisticated PE-backed ABA consolidator’s underwriter was going to want a single-source Maryland DDA continuity binder to confirm the recurring Medicaid revenue thesis through the post-close integration window. The third was the RBT retention curve documentation. Anna knew her blended RBT retention number was 89 percent, but she had not built a documented RBT retention curve that broke retention out by clinic location, by tenure cohort (zero-to-six months, six-to-twelve months, twelve-to-twenty-four months, twenty-four-plus months), and by RBT-to-BCaBA-to-BCBA promotion track participation. A buyer’s investment committee was going to want the RBT retention curve to underwrite the operational-resilience thesis, because RBT turnover is structurally the largest operational risk in any ABA acquisition.
We told Anna honestly: she could go to market now and accept the discount, or she could spend three to four months refreshing the per-clinic BHCOE survey-readiness binders to a uniform Rockville Pike standard with the three-person quality and compliance team driving the work, building a unified Maryland DDA waiver program contract continuity binder, and formalizing a documented RBT retention curve broken out by clinic location, by tenure cohort, and by promotion-track participation. We said the second path would likely command a meaningfully better number from a wider range of buyers, especially a PE-backed ABA consolidator with an underwriter that cared about BHCOE survey continuity, Maryland DDA Medicaid recurring-revenue defensibility, and RBT turnover risk. The realistic buyer pool for a $7.2 million revenue, $1.8 million EBITDA, six-clinic, 480-patient ABA and IDD-focused platform with a 100 percent in-network payor base in the DC metro is concentrated but extremely well-capitalized, and each band of buyer prices the same platform differently. CGK is an active member of the International Business Brokers Association and the M&A Source, both of which give us deep visibility into the active ABA buyer landscape, and we track the regulatory-and-credentialing environment through the Behavior Analyst Certification Board, the Council of Autism Service Providers, and the Behavioral Health Center of Excellence on accreditation standards.
This is the part most brokers skip. Most brokers would have signed Anna that day, taken her to market, and made the commission whether or not the deal was the best one for her. We told her to wait, even though it meant we did not get paid for three months and might never get paid at all if she changed her mind.
Anna went home and waited. She spent the next three months working with her three-person quality and compliance team to refresh the per-clinic BHCOE survey-readiness binders to a uniform Rockville Pike standard across Bethesda, Silver Spring, Gaithersburg, Columbia, and Frederick, building the unified Maryland DDA waiver program contract continuity binder, formalizing the documented RBT retention curve broken out by clinic location, by tenure cohort, and by promotion-track participation, tightening the CentralReach ABA practice management data hygiene across the trailing thirty-six months, and pulling together a pediatrician-referral attribution analysis that documented the per-pediatrician and per-pediatric-practice referral volume across the DC metro. She read background material on ABA M&A through the Council of Autism Service Providers and on BHCOE accreditation standards through the BHCOE itself. She called us back about three months later and said she was ready to sell a behavioral health business that was finally in the shape it needed to be in.
What we did when Anna came back.
What it takes to sell a behavioral health business properly
When a BCBA-D is ready to sell a behavioral health business with CGK, the speed of the on-ramp surprises them. We took Anna’s platform to market in just over six weeks once she got us her updated financials, the refreshed per-clinic BHCOE survey-readiness binders, the unified Maryland DDA waiver program contract continuity binder, the documented RBT retention curve broken out by clinic location, by tenure cohort, and by promotion-track participation, the pediatrician-referral attribution analysis, the trailing thirty-six months of CentralReach ABA practice management data hygiene, the per-clinic patient census trends across the regular ABA cohort and the IDD young-adult day-program cohort, the per-clinic average treatment-hour utilization analysis broken out by program (clinic-based ABA, in-home ABA, IDD day program, telehealth supervision and parent training, in-school consultation), the Maryland Board of Professional Counselors and Therapists licensure documentation across all six BCBAs, the four BCaBA credential documentation, the fifty-eight RBT credentialing files, the per-clinic real-property lease terms on Rockville Pike, Bethesda, Silver Spring, Gaithersburg, Columbia, and Frederick, and the full P&L breakouts across all six sites and across the four program lines. The blind teaser went out to 27 buyers we had pre-qualified, a tighter funnel than other healthcare segments because the ABA M&A buyer pool at this revenue band is structurally concentrated around a small group of well-capitalized PE-backed consolidators (fewer than twenty active ABA platforms operate at this acquisition band nationally).
Why the 100 percent in-network payor mix is the multiple anchor
This is the most important paragraph on the page, so we will say it directly. The 100 percent in-network mix Anna built deliberately over twelve years is what made her practice command a premium ABA multiple, and what made buyers willing to pay top-of-band price. Out-of-network ABA practices are functionally unsellable in 2026 for three structural reasons. First, ABA therapy and IDD services are heavily Medicaid-funded, with the Maryland DDA waiver program (and the equivalent state-level Medicaid waiver programs across most other states) requiring formal in-network credentialing for any provider that bills the waiver, which means an out-of-network practice is structurally locked out of the largest single payor in the entire ABA industry. Second, parents of children with autism virtually all use commercial insurance, and most major commercial carriers have moved to in-network mandates for ABA over the prior several years (CareFirst BCBS, Aetna, UnitedHealthcare, and Cigna all maintain formal in-network ABA credentialing requirements in the Mid-Atlantic), so an out-of-network practice cannot reach the addressable patient base. Third, PE-backed ABA consolidators structurally refuse to acquire out-of-network practices because the patient base is structurally locked out of commercial reimbursement and Medicaid waiver reimbursement. The result is that an in-network ABA platform at Anna’s revenue and EBITDA band, with the Maryland DDA waiver program contract anchoring half the revenue and the commercial in-network panel covering the rest, commands a meaningful premium over an out-of-network operator at the same trailing financials, often a two-to-three-turn EBITDA premium, because the buyer’s underwriter can stand behind the in-network reimbursement rates and the credentialing transferability through the integration window.
The buyer pool for a BHCOE-accredited, in-network ABA platform
Twenty-one of the twenty-seven buyers signed NDAs and received the full Confidential Information Memorandum. Thirteen submitted Indications of Interest after data-room review. Seven advanced to Letters of Intent. We narrowed to five for management presentations. Three re-submitted refined LOIs after the management meetings. Two went into a final-final negotiation cycle. Buyers fell across four buckets we routinely use to think about how to sell a behavioral health business in the autism services and IDD-focused vertical. The first bucket is PE-backed ABA and behavioral health consolidators, active across Detroit, Boston, Dallas, San Diego, and a handful of national platforms operating at the Centria Autism, Hopebridge Pediatric Therapy, BlueSprig Pediatrics, Trumpet Behavioral Health, LEARN Behavioral, and Autism Learning Partners tier, typically running multi-state roll-up theses with central regulatory, credentialing, billing, and IT support, usually pricing on a 7x to 8x EBITDA band on diligence-clean in-network ABA platforms with documented BHCOE survey readiness, Medicaid waiver contract continuity, RBT retention defensibility, and BCBA licensure transferability, and typically operating acquired clinics under their original brand names with central support layered behind them rather than absorbing them into a single national identity. The second bucket is regional Mid-Atlantic ABA operators, privately held, often BCBA-founded, expanding their DC, Maryland, Virginia, and Pennsylvania footprint through targeted acquisitions and typically operating acquired clinics under their original brand names with central administrative support, usually pricing on a 5.5x to 6.5x EBITDA band with stronger BCBA continuity expectations than PE buyers. The third bucket is health system or academic medical center operators running developmental pediatrics vertical-integration theses, the rarest buyer pool but the most strategically valuable when present (a Johns Hopkins, MedStar, or University of Maryland Medical System tier system integrating an ABA platform into its developmental pediatrics service line), occasionally pricing at or above PE multiples when the strategic fit is right but slower to close because of board approval cycles. The fourth bucket is individual BCBA-buyer or small-BCBA-group acquisitions, the rarest at this band because the EBITDA size pushes deal value above SBA capacity, typically focused on single-clinic acquisitions in the $200K to $500K EBITDA range. Each bucket prices the same platform differently. We will note here for context what we are not covering on this page: addiction treatment (substance use disorder and medication-assisted treatment) is a structurally distinct M&A vertical with a different buyer pool (Acadia Healthcare, Discovery Behavioral Health, Pyramid Healthcare, Pinnacle Treatment Centers, BHG Holdings tier), different payor dynamics, different regulatory frameworks (DEA X-waiver compliance, state SUD licensing, CARF accreditation), and a different multi-clinic operating thesis, which is why CGK runs the addiction treatment engagement separately on the related sell an addiction treatment center page. Mental health outpatient practices in the general psychiatric counseling and anxiety-and-depression therapy band (without an ABA, autism, or IDD focus) are a third structurally distinct vertical CGK can advise on, with a different buyer pool again, more concentrated around regional behavioral health operators and individual psychiatrist or psychologist buyers than around PE-backed ABA consolidators.
Anna decided between the top two LOIs. They were materially different. One was a slightly higher headline price from a regional Mid-Atlantic ABA operator with roughly $190 million in revenue across more than 25 acquired ABA clinics, where the six DC metro clinics would absorb into the operator’s central administrative playbook within ninety days, the six BCBAs would absorb under the operator’s standardized BCBA comp model (which sat below the comp model Anna had built), the four BCaBAs and the fifty-eight RBTs would absorb under a different operations and scheduling rhythm, and Anna would transition to a six-month clinical-director-emeritus role with no continuing clinical-leadership presence. The other was a slightly lower headline price from a PE-backed ABA consolidator with approximately $1.1 billion in revenue across more than 250 acquired ABA clinics pre-acquisition, expanding its Mid-Atlantic footprint with Anna’s six-clinic Maryland practice as the DC-metro flagship and the base for further DC, Maryland, and Virginia roll-up, with a long-hold thesis (10-plus years, positioning for a 2030+ second-bite or strategic exit). Under that LOI, the six clinics would continue to operate under their original brand name with central regulatory, credentialing, billing, and IT support from the consolidator, the 85-person W-2 team would stay employed across the six sites, the six BCBAs would absorb at or above their existing comp under the consolidator’s clinical-leadership compensation framework with formal three-to-five-year stay arrangements tied to BCBA licensure continuity and BHCOE survey continuity, the four BCaBAs and the fifty-eight RBTs would retain their roles and pay structure (including the structured supervision pathway toward BCaBA and BCBA credentialing that anchored the 89 percent retention number), the eight case managers and six administrative and billing personnel and three quality and compliance team members would all retain their roles, the CentralReach ABA practice management platform would be retained for the six DC metro clinics through an 18-month integration window, the BHCOE accreditation would be preserved through a continuity-of-survey arrangement, the Maryland DDA waiver program contract would be preserved through a formal Maryland DDA change-of-ownership review, and Anna would step into a 12-month transition consulting role at one day per week before stepping off entirely once the family relocation to Boston was complete. We walked Anna through what each LOI would actually deliver under realistic and pessimistic scenarios, including what the operational continuity would look like for her six BCBAs, her four BCaBAs, her fifty-eight RBTs, her case managers, her front-office team, and her three-person quality and compliance team under each acquisition structure, and what the long-tenure ABA patient cohort and the 120 IDD young-adult clients would experience under each. The PE-backed consolidator deal was the better one for Anna. The 12-month transition consulting structure gave her the structural off-ramp she needed to complete the family relocation to Boston on her own timeline. The team preservation kept her six BCBAs, her four BCaBAs, her fifty-eight RBTs, her case managers, and her quality and compliance team in the roles they had earned. The CentralReach platform preservation through the 18-month integration window kept the daily clinical rhythm intact through the post-close transition.
Through the whole process, the same CGK Managing Director who had taken Anna’s first call three months earlier was the person walking her through every conversation.
The deal Anna took to sell a behavioral health business.
How the deal looks when you sell a behavioral health business with CGK
This is the part of how to sell a behavioral health business that gets the least attention in the trade press and the most attention from BCBAs who have actually closed a transaction: the structure of the consideration package matters more than the headline number, and the structure for an in-network, BHCOE-accredited, multi-clinic ABA and IDD-focused platform with a deep Maryland DDA waiver program contract and a Montgomery County Public Schools partnership is meaningfully different from the structure typical of every other healthcare segment CGK works in. Anna’s deal closed roughly ten months after we restarted the engagement, a typical CGK ABA window because behavioral health M&A involves Maryland Department of Health Developmental Disabilities Administration waiver program change-of-ownership review on each clinic, payor credentialing transfer review across each commercial carrier (CareFirst BCBS, Aetna, UnitedHealthcare, Cigna) and Tricare, transfer of the Maryland Board of Professional Counselors and Therapists licensure across all six BCBAs and the four BCaBAs, transfer of the BHCOE accreditation through a continuity-of-survey arrangement, transfer of the CentralReach ABA practice management platform license, transfer of approximately 480 active ABA patient charts plus 120 IDD young-adult client records under HIPAA-compliant chart-transfer protocols, change-of-control consents on the Montgomery County Public Schools in-school consultation contract, change-of-control consents on the pediatrician-referral relationships across the DC metro, and a more involved pre-close due diligence cycle on the per-clinic BHCOE survey-readiness binders and the RBT retention curve than typical large-band healthcare M&A. The buyer was the PE-backed ABA consolidator with approximately $1.1 billion in revenue across more than 250 acquired ABA clinics pre-acquisition, expanding its Mid-Atlantic footprint with Anna’s six-clinic DC metro practice as the regional flagship and the base for further DC, Maryland, and Virginia roll-up, operating on a 10-plus year long-hold thesis with a 2030+ second-bite or strategic exit horizon. The acquisition structure was an asset purchase rather than a stock purchase, with the six clinics folding into the consolidator at close, the 85-person W-2 team staying employed across the six locations, the six BCBAs absorbing at or above their existing comp with three-to-five-year stay arrangements tied to BCBA licensure continuity and BHCOE survey continuity, the four BCaBAs and the fifty-eight RBTs retaining their roles, pay structure, and structured supervision pathway toward BCaBA and BCBA credentialing, the eight case managers and the six-person front-office and the three-person quality and compliance team retaining their roles, the CentralReach platform retained through an 18-month integration window, the BHCOE accreditation preserved through a continuity-of-survey arrangement, the Maryland DDA waiver program contract preserved through a formal Maryland DDA change-of-ownership review, the original clinic brand name retained with central consolidator support layered behind it, and Anna transitioning to a 12-month transition consulting role at one day per week before stepping off once the family relocation to Boston was complete.
The total deal economic value was approximately $13.5 million, roughly 7.5 times trailing EBITDA, a premium ABA multiple driven by the 100 percent in-network payor mix, the BHCOE accreditation, the 89 percent twelve-month RBT retention rate against an industry average closer to 55 to 65 percent, the six-clinic geographic moat across Montgomery County and Howard County, the Maryland DDA waiver program contract that anchored half the practice revenue, the Montgomery County Public Schools partnership that delivered institutional credibility plus the in-school consultation revenue line, the pediatrician referral pipeline across the DC metro, the Maryland Board of Professional Counselors and Therapists licensure documented across all six BCBAs, the bilingual English-Russian intake capacity, the CentralReach technology standardization across the six clinics, the twelve-year operating history under a single founding BCBA-D, and the documented RBT retention curve and unified Maryland DDA continuity binder Anna had built during the three-month wait period. About 70 percent of it came as cash at closing, in line with what a sophisticated PE-backed ABA consolidator typically structures on a multi-clinic in-network ABA platform. About 10 percent was held back in escrow for 15 months, an extended escrow window because the Maryland DDA waiver program Medicaid audit cycle and the payor credentialing transfer cycle both extend past the typical twelve-month healthcare escrow window. The remaining 20 percent was a rollover-as-equity stake into the consolidator’s holding company, with Anna’s existing equity converting into the consolidator’s holding-company partnership interests on a vesting schedule tied to her continued 12-month transition consulting role and to the six BCBAs’ continued employment through the integration window (ABA rollover percentages run 15 to 25 percent because the consolidators specifically tie part of the sale value to the clinical-director’s continued board-certification continuity, since the BCBA-D credential is the Maryland licensing anchor for the practice). The numbers add up to one hundred. Wire hit on a Friday morning at 10:32 a.m. while Anna was at the Rockville Pike main clinic walking through the open clinic floor where four RBTs were running structured play sessions with five-year-olds working on language acquisition skills.
Anna stayed on as a transition consultant for the consolidator’s Mid-Atlantic region for 12 months after closing, one day per week, so she could personally introduce each of the six BCBAs to the consolidator’s central regulatory and clinical-leadership team, walk her director of clinical services through the consolidator’s central credentialing, billing, and IT playbook for ABA, oversee the integration of the CentralReach ABA practice management platform onto the consolidator’s national clinical-data infrastructure on a managed timeline, oversee the BHCOE survey continuity arrangement through the next survey cycle, oversee the Maryland DDA waiver program change-of-ownership review on each of the six clinics, and shape the consolidator’s DC, Maryland, and Virginia expansion strategy across two adjacent markets the consolidator was actively in conversation with in Northern Virginia and Anne Arundel County. After 12 months, with the family fully settled in Boston, Anna stepped off entirely, with the rollover-as-equity stake in the consolidator’s holding company continuing to vest on a multi-year schedule tied to the platform’s overall performance.
What happened to Anna’s people and her patients.
The people-side of how to sell a behavioral health business usually weighs heavier on the founding BCBA than the financial-side, even when the financial-side is what triggers the call to a broker in the first place. Anna cared most about her six BCBAs (the credentialed clinical layer anchoring each of the six sites), her four BCaBAs who supported the BCBA bench, her fifty-eight RBTs who delivered the front-line direct-service work and were the operational backbone of the practice, her eight case managers who coordinated the pediatrician-referral, Montgomery County Public Schools, and Maryland DDA waiver program workflows, her six-person administrative and billing team, and her three-person quality and compliance team that owned the BHCOE survey, the Maryland licensure renewals, the Maryland DDA provider contract, and the payor credentialing rhythm. She also cared about the patient base: roughly 480 active ABA patients across the six clinics, the average 3.4-year tenure, the 89 percent twelve-month RBT retention rate that meant most ABA families had the same therapy team year after year, the long-tenure cohort that had been with the practice from age four through age eleven and beyond, and the 120 IDD young-adult clients across the day programs who had aged into the IDD continuation services from the regular ABA cohort. The PE-backed consolidator buyer was a long-hold operator that intended to actually preserve the operational rhythm of the six DC metro clinics through the integration window, operating each clinic under its original brand name with central regulatory, credentialing, billing, and IT support layered behind it rather than absorbing them into a single national identity. That made the people part substantially cleaner than it would have been under the higher-headline-price regional Mid-Atlantic ABA operator deal that wanted to absorb the platform into a single central administrative playbook within ninety days.
The buyer kept all 85 W-2 employees, honored the existing pay structure across BCBAs, BCaBAs, RBTs, case managers, front-office, and quality and compliance, and committed to retaining the six BCBAs under three-to-five-year stay arrangements tied to BCBA licensure continuity and BHCOE survey continuity, the four BCaBAs continuing in their assistant-analyst supervision-load roles, the fifty-eight RBTs continuing on direct-service delivery with the structured supervision pathway toward BCaBA and BCBA credentialing fully preserved, the eight case managers continuing on the pediatrician-referral, Montgomery County Public Schools, and Maryland DDA waiver program workflows, the six-person front-office administrative and billing team continuing in their roles, and the three-person quality and compliance team continuing on the BHCOE survey, the Maryland Board of Professional Counselors and Therapists license renewals across all six BCBAs, the Maryland DDA provider contract compliance, and the payor credentialing rhythm. The 480 active ABA patient cohort and the 120 IDD young-adult clients transferred under HIPAA-compliant chart-transfer protocols on a managed timeline, with continuity of care language preserved across the consolidator’s central clinical platform. The CentralReach ABA practice management platform was retained for the six DC metro clinics through an 18-month integration window before any consolidation onto the consolidator’s national clinical-data infrastructure. The BHCOE accreditation transferred under a continuity-of-survey arrangement that preserved the practice’s top-15-percent regulatory standing through the next survey cycle. The Maryland DDA waiver program contract transferred under a formal Maryland Department of Health change-of-ownership review on each of the six clinics, with the recurring Medicaid revenue line preserved through the post-close audit window. The Montgomery County Public Schools in-school consultation contract transferred under a change-of-control consent that preserved the institutional credibility and the in-school consultation revenue line through the rebrand-free integration window. The pediatrician-referral relationships across the DC metro pediatric practices transferred under change-of-control consents that preserved the largest acquisition channel for new ABA patients. The per-clinic real-property leases on Rockville Pike, Bethesda, Silver Spring, Gaithersburg, Columbia, and Frederick transferred cleanly under the consolidator’s real-estate group. The bilingual English-Russian intake capacity stayed intact because the team and the technology and the brand and the operational rhythm stayed in place.
Anna was at the Rockville Pike main clinic on a Friday morning when the wire confirmation came through. ABA closings often happen at the end of the week to coincide with month-end clinical reporting cycles. She walked through the open clinic floor where four RBTs were running structured play sessions with five-year-olds working on language acquisition skills. She did not interrupt them. She drove back to the Bethesda house and called Pavel at NIH. She said in Russian: “Готово, любовь моя.” It is done, my love. Pavel was in a hallway between meetings. He said back: “Тебя люблю.” I love you. They sat down that evening and started planning the Boston move week by week for the first time on a real timeline. Sasha came home from school at one point with a stack of brochures about the Boston public school system, and Mira came home with a list of questions about whether the Boston house would have a yard. Anna and Pavel sat at the kitchen table and answered them.
What Anna told us afterward.
Why BCBAs who sell a behavioral health business with CGK keep coming back
Most BCBAs who sell a behavioral health business do not call the broker again in the first year. The ones who do call usually want to talk about the parts of the engagement that, in retrospect, mattered more than they realized at the time. About four months after closing, while she was back in Rockville for a final transition-consulting site visit, Anna called the Managing Director who had run her engagement. She said two things that the Managing Director still tells new sellers about.
The first was about the three-month wait. She said: “Three of the buyers who had been calling me were ready to sign LOIs in forty-five days, and two different healthcare M&A consultants I had talked to before you told me they could take me to market right then with the per-clinic BHCOE survey-readiness binders still uneven across Bethesda, Silver Spring, Gaithersburg, Columbia, and Frederick, with the Maryland DDA waiver program contract continuity binder still scattered, and with the RBT retention curve still undocumented. The reason I sold with you is that you told me the truth about how my 100 percent in-network payor base, my BHCOE accreditation, my 89 percent RBT retention rate, my Maryland DDA waiver program contract, my Montgomery County Public Schools partnership, and my six-clinic geographic moat were actually being valued by a sophisticated PE-backed ABA consolidator underwriter, the truth about what the per-clinic BHCOE survey-readiness refresh would buy me in LOI conversations three months later, the truth about what the unified Maryland DDA continuity binder would buy me in management-presentation conversations, and the truth about what the documented RBT retention curve would buy me in investment-committee approval. You told me what would happen to the price if I went out without fixing those things. I would have left two million dollars on the table, my six BCBAs would have folded into a worse comp tier under a different operator, and my fifty-eight RBTs and my three-person quality and compliance team would have absorbed under a buyer with a tighter integration timeline.”
The second was about who she sold to. She said: “I almost signed with the higher-headline-price regional Mid-Atlantic ABA operator because the number on the top line was bigger and they told me they could close in ninety days. The fact that you walked me through what each buyer would actually do with my six BCBAs, my four BCaBAs, my fifty-eight RBTs, my case managers, my front-office team, my three-person quality and compliance team, the six clinics I had built across twelve years, the BHCOE accreditation I had spent two years earning, the Maryland DDA waiver program contract I had spent twelve years building, the Montgomery County Public Schools partnership that gave me institutional credibility, and the 100 percent in-network payor mix I had spent twelve years building one credentialing application at a time, what each buyer’s regulatory-and-clinical integration thesis would mean for the long-tenure ABA cohort and the IDD young-adult day-program clients three and five years out, and how a PE-backed consolidator with a brand-preservation thesis was structurally different from a regional operator with a ninety-day full-absorption thesis, is a conversation I never even thought to have until you raised it. I sold to a buyer who is actually going to keep the operational rhythm and the brand and the team and the clinical leadership intact through the long-hold window, and the 12-month transition consulting role you negotiated is what is letting me complete the Boston move on my own timeline. That was not on the original LOI. You pushed for it.”
This is what we mean when we say we sit with you in the decision, not just the transaction. Anna is one composite story, but the pattern is real. The BCBAs we work with who decide to sell a behavioral health business usually find their way to us through versions of Anna’s situation, and the relationships start with a long listening session and a free walkthrough, not a pitch.
Ready to sell a behavioral health business? Where are you in Anna’s story?
If you are starting to think about how to sell a behavioral health business in the autism services, ABA, or IDD-focused vertical, we should talk. There is no commitment and no pressure. The first conversation is free. The valuation walkthrough that follows is free when you are seriously thinking about selling, whether that is in a year, five years, or longer. We only charge for formal written valuations, and only when you actually need one for a partnership buyout, estate planning, or another documentary purpose. Submit the form and a senior CGK Managing Director will reach out within one business day.
If you are Anna at month 1: just exploring
You are not sure if you want to sell yet. The ABA M&A landscape keeps shifting under PE-backed consolidator activity and state Medicaid waiver program rate changes, your in-network payor mix is meaningful but the unified Medicaid waiver program continuity binder is scattered, your BHCOE accreditation is real but the per-clinic survey-readiness binders are uneven across satellite sites, your RBT retention number is meaningful but the cohort retention curve is undocumented, your BCBA licensure documentation is in place but not consolidated for buyer review, your CentralReach data hygiene is uneven across the trailing thirty-six months, twelve years of running the platform is starting to tell you something, your family circumstances are pulling you toward a different geography, you are curious about how a buyer would value your ABA-versus-IDD-versus-school-consultation mix, or maybe a PE-backed ABA consolidator or a regional Mid-Atlantic ABA operator has been calling you. Most of our best engagements start here. Submit the form and we will schedule a working session. You walk away with a real number and a clear sense of what to do next, with no obligation to do anything.
If you are Anna at month 3: ready to go
You have done the work to clean up the platform. The financials are tight. Your per-clinic BHCOE survey-readiness binders are refreshed to a uniform standard across the main clinic and each satellite. Your unified state Medicaid waiver program contract continuity binder is documented across each clinic and each service line. Your RBT retention curve is broken out by clinic location, by tenure cohort, and by promotion-track participation. Your pediatrician-referral attribution analysis is documented across each referring pediatric practice. Your BCBA and BCaBA credentialing documentation is consolidated across all clinical staff. Your CentralReach ABA practice management data is pulled into a buyer-grade report for the trailing thirty-six months. Your clinical-leadership succession plan is named and pre-negotiated. Maybe a buyer is already in the conversation. You want to run a real process. Submit the form and we will be in touch within a business day to talk about timing, scope, and what your first 30 days as a CGK seller would look like.
If you are not sure where you are
Most BCBAs are not sure. Submit the form and start with the conversation. We will figure out together where you are. We are equally happy to tell you to wait twelve months as we are to take you to market in six weeks.
Or call us directly at (888) 858-7191.
Start your own story
A senior CGK Managing Director will respond within one business day. Strictly confidential. For BCBA-owners and physician-owners of ABA therapy, autism services, and IDD-focused behavioral health practices doing $1.5M+ in annual revenue, including clinic-based ABA, in-home ABA, IDD adolescent and young-adult day-program services, telehealth-delivered parent training and ABA supervision, and in-school behavioral consultation operators. The first conversation and the valuation walkthrough that follows are free for any seller seriously thinking about selling, on any horizon.
Confidential. No obligation. Direct routing to a named CGK business broker, not a junior screener.
One of these eight people would lead your engagement.
When you decide to sell a behavioral health business with CGK, one named senior Managing Director stays with you from the first call through the wire transfer, just like Anna’s Managing Director stayed with her for three months and then for the engagement that followed. Our Managing Directors come from Wall Street investment banks, hedge funds, Fortune 500 corporate finance, and operating-business leadership. Cornell MBA. U Chicago Booth MBA. CFA. CMT. Naval Academy. Goldman Sachs. Merrill Lynch. Deutsche Bank. AIG. T. Rowe Price.
What sellers say after they sell a behavioral health business (and other businesses) with CGK
I could not be happier with the experience I had selling my business with CGK. Greg did a detailed analysis of my business and helped me price and position it right for the market. After receiving multiple offers at full asking price, the rest of the process went very smoothly, and we closed in less than two months.
Hanna M.Selling my business was a once-in-a-lifetime experience, and I’m incredibly grateful to have had Wes by my side throughout the process. He brought perspective, pushed when necessary, and always had my best interests in mind. His experience and strategic approach allowed me to maximize the sale price while minimizing long-term risk and obligations. If I had to do it all over again, I wouldn’t hesitate to choose him as my broker.
Adam NevilleDerik located multiple interested strategic buyers that produced more than one serious offer. The negotiations were tough but Greg and Derik’s experience helped us overcome. We got a great result for our employees and for the owners. We would recommend them without reservation.
Bob TaylorWe sold a business that was 47 years old and being run by second generation within a year of working with Wes. CGK has a system that attracts serious prospects to review opportunities. Wes was able to make the overwhelming feeling of selling easy and to a certain extent enjoyable. I never felt alone or in the dark throughout the entire process.
Jennifer WilliamsWe decided to sell our company in 2025. Talked to another M&A company in the Houston area. We felt very comfortable with Greg and Matthew at CGK. Could not have made a better choice. From day 1 till final closing and even after 30+ days, they have been here helping us with documents and support during the transition. Thanks can not be said enough.
Rickey ThomasInside the Blueprint, on Bloomberg TV and Fox Business News.
Anna’s husband Pavel was the one who first sent her a clip of CGK on Bloomberg. He had been watching the segment in the Bethesda kitchen on a Saturday morning while Sasha was studying for an Algebra II test, and he recognized the firm name from a healthcare M&A trade article on how to sell a behavioral health business that Anna had read a few months earlier. He texted her the link with a note that read “Look at this. This is the firm. Same one from your trade article.” CGK Business Sales is featured on Inside the Blueprint, the syndicated business television series. Our episode aired on Bloomberg TV and Fox Business News. Watch the segment, then start a confidential conversation.
The CGK office Anna called was the CGK Washington, DC office. Yours might be one of these.
When you sell a behavioral health business with CGK, whichever office you reach, you get the entire firm. Anna worked with a CGK Managing Director based out of the firm’s Washington, DC office covering the broader DC metro and Mid-Atlantic, but her deal benefited from a buyer pool we sourced firm-wide, including the PE-backed ABA consolidator that ultimately won the engagement and is now using the six DC metro clinics as its Mid-Atlantic regional flagship and the base for further DC, Maryland, and Virginia roll-up. Click any city to learn about our local presence and the named Managing Director leading that market.
Other Questions Anna and Other Behavioral Health Sellers Ask Us
Practical answers to what comes up before, during, and after the kind of engagement Anna went through, when you sell a behavioral health business with CGK.